Injecting drug use is associated with a more rapid CD4 cell decline among treatment naïve HIV‐positive patients in Indonesia

Abstract

BackgroundIt remains unclear whether the natural course of human immunodeficiency virus (HIV) differs in subjects infected through injecting drug use (IDU) and no data have been published from low- or middle-income countries. We addressed this question in an urban cohort in Indonesia, which is experiencing a rapidly growing HIV epidemic strongly driven by IDU.MethodsAll antiretroviral treatment (ART) naïve HIV-positive patients who had at least two subsequent CD4 cell counts available before starting ART were included in this study. We examined the association between IDU and CD4 cell decline using a linear mixed model, with adjustment for possible confounders such as HIV viral load and hepatitis C antibodies.ResultsAmong 284 HIV-positive ART naïve patients, the majority were male (56%) with a history of IDU (79% among men). People with a history of IDU had a statistically significant faster decline in CD4 cells (p<0.001). Based on our data, patients with a history of IDU would have an average 33% decline in CD4 cells after one year without ART, compared with a 22% decline among non-users. At two years, the decline would average 66 and 40%, respectively. No other factor was significantly associated with CD4 cell decline.ConclusionsWe show that a history of IDU is associated with a more rapid CD4 cell natural decline among HIV-positive individuals in Indonesia. These findings have implications for monitoring ART naïve patients with a history of IDU and for starting ART in this group.

Results from a Method for Estimating HIV Incidence Based on the First Cd4 Count among Treatment-Naïve Cases: Brazil, 2004-2013

“…During more than 30 years of the HIV/AIDS epidemic, Brazil has maintained a concentrated epidemic, with an HIV prevalence rate less than 1% in the general population [39]. Despite earlier concerns about an increase in heterosexual cases and "feminization" of the epidemic, it seems the actual scenario is the predominance of HIV infection among MSM, similar to data from many other countries [49,50].…”

“…Although the assumption that the square root of CD4 count is linearly related to time since infection has frequently been used in different settings [12,14,15], other types of functions have also been proposed [38,39]. In addition, Rice and collaborators have suggested that besides age at diagnosis, ethnicity and region of birth are significant predictors of rate of CD4 decrease [15].…”

Utility of QuantiFERON-TB Gold In-Tube Test in the Diagnosis of Latent TB in HIV-Positive Patients in a Medium-TB Burden Country

“…This finding is compatible with some similar studies and might be because of their impaired cellmediated immunity and more rapid CD4 count decline among these patients. 38,39 It is not conclusively defined which diagnostic test is better to evaluate LTBI in HIV-infected patients, and decisions about this subject is influenced by some factors such as cost, accessibility, and patient convenience. 39 Considering imposed cost caused by dissemination of disease in the community and treatment of the patients would convince us that QFT performance and even chemoprophylaxis of false positive ones would be more cost-effective.…”

Study of Cd4 Count in Hiv Patients on Haart Therapy

“…Indeed, the stable or increased incidence of HIV in MSM in some communities where widespread use of ART has been established emphasises the concern that not enough is known about treatment as prevention for this crucial population. 28 There is interest in expanding ART to prevent HIV transmission, but in the group with the highest levels of ART use, men-who-have-sex-with-men (MSM), numbers of new infections diagnosed each year have not decreased as ART coverage has increased for reasons which remain unclear. ART has almost certainly exerted a limiting effect on incidence.…”